Error: Could not add to watchlist. X

Medivir AB

+ Watchlist
MVR:GR
Frankfurt
8.35
EUR
0.06
0.77%
As of 10:22:21 ET on 06/02/2015.
Open
8.53
Day Range
8.35 - 8.70
Volume
0
Previous Close
8.41
52Wk Range
8.04 - 15.33
1 Yr Return
-36.30%
Current P/E Ratio (TTM)
-
Earnings per Share (SEK) (TTM)
-
Market Cap (m EUR)
227.669
Shares Outstanding (m)
26.360
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.
ADDRESS
Lunastigen 7
Huddinge, 141 44
Sweden
PHONE
46-8-546-831-00
  • Niklas Prager
    President/CEO
  • Ola Burmark
    CFO
  • Christine Lind
    Exec VP:Strategic Business Dev
  • Richard Bethell
    Exec VP:Discovery Research
  • Henrik Krook
    Exec VP:Commercial
Show More